Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Index by author

March 01, 2005; Volume 33,Issue 3
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Akiyama, Taro E.

    1. You have access
      THE CYP2E1-HUMANIZED TRANSGENIC MOUSE: ROLE OF CYP2E1 IN ACETAMINOPHEN HEPATOTOXICITY
      Connie Cheung, Ai-Ming Yu, Jerrold M. Ward, Kristopher W. Krausz, Taro E. Akiyama, Lionel Feigenbaum and Frank J. Gonzalez
      Drug Metabolism and Disposition March 2005, 33 (3) 449-457; DOI: https://doi.org/10.1124/dmd.104.002402
  2. André, F.

    1. You have access
      CYTOCHROME P450-MEDIATED OXIDATION OF GLUCURONIDE DERIVATIVES: EXAMPLE OF ESTRADIOL-17β-GLUCURONIDE OXIDATION TO 2-HYDROXY-ESTRADIOL-17β-GLUCURONIDE BY CYP 2C8
      M. Delaforge, A. Pruvost, L. Perrin and F. André
      Drug Metabolism and Disposition March 2005, 33 (3) 466-473; DOI: https://doi.org/10.1124/dmd.104.002097
  3. Annaert, Pieter P.

    1. You have access
      ASSESSMENT OF DRUG INTERACTIONS IN HEPATOBILIARY TRANSPORT USING RHODAMINE 123 IN SANDWICH-CULTURED RAT HEPATOCYTES
      Pieter P. Annaert and Kim L. R. Brouwer
      Drug Metabolism and Disposition March 2005, 33 (3) 388-394; DOI: https://doi.org/10.1124/dmd.104.001669
  4. Austin, Rupert P.

    1. You have access
      THE BINDING OF DRUGS TO HEPATOCYTES AND ITS RELATIONSHIP TO PHYSICOCHEMICAL PROPERTIES
      Rupert P. Austin, Patrick Barton, Sarfraz Mohmed and Robert J. Riley
      Drug Metabolism and Disposition March 2005, 33 (3) 419-425; DOI: https://doi.org/10.1124/dmd.104.002436

B

  1. Barton, Patrick

    1. You have access
      THE BINDING OF DRUGS TO HEPATOCYTES AND ITS RELATIONSHIP TO PHYSICOCHEMICAL PROPERTIES
      Rupert P. Austin, Patrick Barton, Sarfraz Mohmed and Robert J. Riley
      Drug Metabolism and Disposition March 2005, 33 (3) 419-425; DOI: https://doi.org/10.1124/dmd.104.002436
  2. Bessette, Erin E.

    1. You have access
      MECHANISMS OF ARSENITE-MEDIATED DECREASES IN BENZO[K]FLUORANTHENE-INDUCED HUMAN CYTOCHROME P4501A1 LEVELS IN HEPG2 CELLS
      Erin E. Bessette, Michael J. Fasco, Brian T. Pentecost and Laurence S. Kaminsky
      Drug Metabolism and Disposition March 2005, 33 (3) 312-320; DOI: https://doi.org/10.1124/dmd.104.002212
  3. Brouwer, Kim L. R.

    1. You have access
      ASSESSMENT OF DRUG INTERACTIONS IN HEPATOBILIARY TRANSPORT USING RHODAMINE 123 IN SANDWICH-CULTURED RAT HEPATOCYTES
      Pieter P. Annaert and Kim L. R. Brouwer
      Drug Metabolism and Disposition March 2005, 33 (3) 388-394; DOI: https://doi.org/10.1124/dmd.104.001669
  4. Buratti, Franca M.

    1. You have access
      MALATHION BIOACTIVATION IN THE HUMAN LIVER: THE CONTRIBUTION OF DIFFERENT CYTOCHROME P450 ISOFORMS
      Franca M. Buratti, Alessandra D'Aniello, Maria Teresa Volpe, Annarita Meneguz and Emanuela Testai
      Drug Metabolism and Disposition March 2005, 33 (3) 295-302; DOI: https://doi.org/10.1124/dmd.104.001693

C

  1. Chaudhary, Ashok

    1. You have access
      DEVELOPMENT AND VALIDATION OF A HIGH-THROUGHPUT RADIOMETRIC CYP3A4/5 INHIBITION ASSAY USING TRITIATED TESTOSTERONE
      Annalise Di Marco, Isabella Marcucci, Maria Verdirame, José Pérez, Manuel Sanchez, Fernando Peláez, Ashok Chaudhary and Ralph Laufer
      Drug Metabolism and Disposition March 2005, 33 (3) 349-358; DOI: https://doi.org/10.1124/dmd.104.002873
    2. You have access
      DEVELOPMENT AND VALIDATION OF A HIGH-THROUGHPUT RADIOMETRIC CYP2C9 INHIBITION ASSAY USING TRITIATED DICLOFENAC
      Annalise Di Marco, Isabella Marcucci, Ashok Chaudhary, Marina Taliani and Ralph Laufer
      Drug Metabolism and Disposition March 2005, 33 (3) 359-364; DOI: https://doi.org/10.1124/dmd.104.002915
  2. Chen, Mei-Ling

    1. You have access
      DO MEN AND WOMEN DIFFER IN PROXIMAL SMALL INTESTINAL CYP3A OR P-GLYCOPROTEIN EXPRESSION?
      Mary F. Paine, Shana S. Ludington, Mei-Ling Chen, Paul W. Stewart, Shiew-Mei Huang and Paul B. Watkins
      Drug Metabolism and Disposition March 2005, 33 (3) 426-433; DOI: https://doi.org/10.1124/dmd.104.002469
  3. Cheung, Connie

    1. You have access
      THE CYP2E1-HUMANIZED TRANSGENIC MOUSE: ROLE OF CYP2E1 IN ACETAMINOPHEN HEPATOTOXICITY
      Connie Cheung, Ai-Ming Yu, Jerrold M. Ward, Kristopher W. Krausz, Taro E. Akiyama, Lionel Feigenbaum and Frank J. Gonzalez
      Drug Metabolism and Disposition March 2005, 33 (3) 449-457; DOI: https://doi.org/10.1124/dmd.104.002402
  4. Chung, Suk-Jae

    1. You have access
      SATURABLE DISTRIBUTION OF TACRINE INTO THE STRIATAL EXTRACELLULAR FLUID OF THE RAT: EVIDENCE OF INVOLVEMENT OF MULTIPLE ORGANIC CATION TRANSPORTERS IN THE TRANSPORT
      Jong-Hyuk Sung, Kyung-Ha Yu, Jin-Sun Park, Takashi Tsuruo, Dae-Duk Kim, Chang-Koo Shim and Suk-Jae Chung
      Drug Metabolism and Disposition March 2005, 33 (3) 440-448; DOI: https://doi.org/10.1124/dmd.104.002220
  5. Coburn, Robert A.

    1. You have access
      NEW 4-ARYL-1,4-DIHYDROPYRIDINES AND 4-ARYLPYRIDINES AS P-GLYCOPROTEIN INHIBITORS
      Xiao-fei Zhou, Linping Zhang, Elaine Tseng, Elizabeth Scott-Ramsay, Jerome J. Schentag, Robert A. Coburn and Marilyn E. Morris
      Drug Metabolism and Disposition March 2005, 33 (3) 321-328; DOI: https://doi.org/10.1124/dmd.104.002089

D

  1. D'Aniello, Alessandra

    1. You have access
      MALATHION BIOACTIVATION IN THE HUMAN LIVER: THE CONTRIBUTION OF DIFFERENT CYTOCHROME P450 ISOFORMS
      Franca M. Buratti, Alessandra D'Aniello, Maria Teresa Volpe, Annarita Meneguz and Emanuela Testai
      Drug Metabolism and Disposition March 2005, 33 (3) 295-302; DOI: https://doi.org/10.1124/dmd.104.001693
  2. Dale, Ola

    1. You have access
      METABOLISM OF ALFENTANIL BY CYTOCHROME P4503A (CYP3A) ENZYMES
      Theresa Mariero Klees, Pamela Sheffels, Ola Dale and Evan D. Kharasch
      Drug Metabolism and Disposition March 2005, 33 (3) 303-311; DOI: https://doi.org/10.1124/dmd.104.002709
  3. Delaforge, M.

    1. You have access
      CYTOCHROME P450-MEDIATED OXIDATION OF GLUCURONIDE DERIVATIVES: EXAMPLE OF ESTRADIOL-17β-GLUCURONIDE OXIDATION TO 2-HYDROXY-ESTRADIOL-17β-GLUCURONIDE BY CYP 2C8
      M. Delaforge, A. Pruvost, L. Perrin and F. André
      Drug Metabolism and Disposition March 2005, 33 (3) 466-473; DOI: https://doi.org/10.1124/dmd.104.002097
  4. Di Marco, Annalise

    1. You have access
      DEVELOPMENT AND VALIDATION OF A HIGH-THROUGHPUT RADIOMETRIC CYP2C9 INHIBITION ASSAY USING TRITIATED DICLOFENAC
      Annalise Di Marco, Isabella Marcucci, Ashok Chaudhary, Marina Taliani and Ralph Laufer
      Drug Metabolism and Disposition March 2005, 33 (3) 359-364; DOI: https://doi.org/10.1124/dmd.104.002915

E

  1. Ekins, Sean

    1. You have access
      A NOVEL METHOD FOR VISUALIZING NUCLEAR HORMONE RECEPTOR NETWORKS RELEVANT TO DRUG METABOLISM
      Sean Ekins, Eugene Kirillov, Eugene A. Rakhmatulin and Tatiana Nikolskaya
      Drug Metabolism and Disposition March 2005, 33 (3) 474-481; DOI: https://doi.org/10.1124/dmd.104.002717
  2. El-Kadi, Ayman O. S.

    1. You have access
      tert-BUTYLHYDROQUINONE IS A NOVEL ARYL HYDROCARBON RECEPTOR LIGAND
      Negar Gharavi and Ayman O. S. El-Kadi
      Drug Metabolism and Disposition March 2005, 33 (3) 365-372; DOI: https://doi.org/10.1124/dmd.104.002253

F

  1. Fasco, Michael J.

    1. You have access
      MECHANISMS OF ARSENITE-MEDIATED DECREASES IN BENZO[K]FLUORANTHENE-INDUCED HUMAN CYTOCHROME P4501A1 LEVELS IN HEPG2 CELLS
      Erin E. Bessette, Michael J. Fasco, Brian T. Pentecost and Laurence S. Kaminsky
      Drug Metabolism and Disposition March 2005, 33 (3) 312-320; DOI: https://doi.org/10.1124/dmd.104.002212
  2. Feigenbaum, Lionel

    1. You have access
      THE CYP2E1-HUMANIZED TRANSGENIC MOUSE: ROLE OF CYP2E1 IN ACETAMINOPHEN HEPATOTOXICITY
      Connie Cheung, Ai-Ming Yu, Jerrold M. Ward, Kristopher W. Krausz, Taro E. Akiyama, Lionel Feigenbaum and Frank J. Gonzalez
      Drug Metabolism and Disposition March 2005, 33 (3) 449-457; DOI: https://doi.org/10.1124/dmd.104.002402

G

  1. Gaman, Emily A.

    1. You have access
      SELECTIVE INHIBITION OF HUMAN CYTOCHROME P4502C8 BY MONTELUKAST
      Robert L. Walsky, R. Scott Obach, Emily A. Gaman, Jean-Paul R. Gleeson and William R. Proctor
      Drug Metabolism and Disposition March 2005, 33 (3) 413-418; DOI: https://doi.org/10.1124/dmd.104.002766
  2. Gharavi, Negar

    1. You have access
      tert-BUTYLHYDROQUINONE IS A NOVEL ARYL HYDROCARBON RECEPTOR LIGAND
      Negar Gharavi and Ayman O. S. El-Kadi
      Drug Metabolism and Disposition March 2005, 33 (3) 365-372; DOI: https://doi.org/10.1124/dmd.104.002253
  3. Gleeson, Jean-Paul R.

    1. You have access
      SELECTIVE INHIBITION OF HUMAN CYTOCHROME P4502C8 BY MONTELUKAST
      Robert L. Walsky, R. Scott Obach, Emily A. Gaman, Jean-Paul R. Gleeson and William R. Proctor
      Drug Metabolism and Disposition March 2005, 33 (3) 413-418; DOI: https://doi.org/10.1124/dmd.104.002766
  4. Gonzalez, Frank J.

    1. You have access
      THE CYP2E1-HUMANIZED TRANSGENIC MOUSE: ROLE OF CYP2E1 IN ACETAMINOPHEN HEPATOTOXICITY
      Connie Cheung, Ai-Ming Yu, Jerrold M. Ward, Kristopher W. Krausz, Taro E. Akiyama, Lionel Feigenbaum and Frank J. Gonzalez
      Drug Metabolism and Disposition March 2005, 33 (3) 449-457; DOI: https://doi.org/10.1124/dmd.104.002402

H

  1. Haraguchi, Koichi

    1. You have access
      COMPARATIVE METABOLISM OF POLYCHLORINATED BIPHENYLS AND TISSUE DISTRIBUTION OF PERSISTENT METABOLITES IN RATS, HAMSTERS, AND GUINEA PIGS
      Koichi Haraguchi, Nobuyuki Koga and Yoshihisa Kato
      Drug Metabolism and Disposition March 2005, 33 (3) 373-380; DOI: https://doi.org/10.1124/dmd.104.002444
  2. Hasegawa, Ryuichi

    1. You have access
      RACIAL VARIABILITY IN HAPLOTYPE FREQUENCIES OF UGT1A1 AND GLUCURONIDATION ACTIVITY OF A NOVEL SINGLE NUCLEOTIDE POLYMORPHISM 686C> T (P229L) FOUND IN AN AFRICAN-AMERICAN
      Nahoko Kaniwa, Kouichi Kurose, Hideto Jinno, Toshiko Tanaka-Kagawa, Yoshiro Saito, Mayumi Saeki, Jun-ichi Sawada, Masahiro Tohkin and Ryuichi Hasegawa
      Drug Metabolism and Disposition March 2005, 33 (3) 458-465; DOI: https://doi.org/10.1124/dmd.104.001800
  3. He, Xiao-Yang

    1. You have access
      HUMAN CYTOCHROME P450 2S1: LACK OF ACTIVITY IN THE METABOLIC ACTIVATION OF SEVERAL CIGARETTE SMOKE CARCINOGENS AND IN THE METABOLISM OF NICOTINE
      Shou-Lin Wang, Xiao-Yang He and Jun-Yan Hong
      Drug Metabolism and Disposition March 2005, 33 (3) 336-340; DOI: https://doi.org/10.1124/dmd.104.002923
  4. Hirao, Yukihiro

    1. You have access
      RELATIONSHIPS AMONG PLASMA [2-13C]URACIL CONCENTRATIONS, BREATH 13CO2 EXPIRATION, AND DIHYDROPYRIMIDINE DEHYDROGENASE (DPD) ACTIVITY IN THE LIVER IN NORMAL AND DPD-DEFICIENT DOGS
      Makoto Inada, Yukihiro Hirao, Toshihisa Koga, Minoru Itose, Jun-ichi Kunizaki, Takefumi Shimizu and Hitoshi Sato
      Drug Metabolism and Disposition March 2005, 33 (3) 381-387; DOI: https://doi.org/10.1124/dmd.104.001032
  5. Ho, Shung-Tai

    1. You have access
      IN VITRO AND IN VIVO EVALUATION OF THE METABOLISM AND PHARMACOKINETICS OF SEBACOYL DINALBUPHINE
      Li-Heng Pao, Cheng-Huei Hsiong, Oliver Yoa-Pu Hu, Jhi-Jung Wang and Shung-Tai Ho
      Drug Metabolism and Disposition March 2005, 33 (3) 395-402; DOI: https://doi.org/10.1124/dmd.104.002451
  6. Hong, Jun-Yan

    1. You have access
      HUMAN CYTOCHROME P450 2S1: LACK OF ACTIVITY IN THE METABOLIC ACTIVATION OF SEVERAL CIGARETTE SMOKE CARCINOGENS AND IN THE METABOLISM OF NICOTINE
      Shou-Lin Wang, Xiao-Yang He and Jun-Yan Hong
      Drug Metabolism and Disposition March 2005, 33 (3) 336-340; DOI: https://doi.org/10.1124/dmd.104.002923
  7. Hsiong, Cheng-Huei

    1. You have access
      IN VITRO AND IN VIVO EVALUATION OF THE METABOLISM AND PHARMACOKINETICS OF SEBACOYL DINALBUPHINE
      Li-Heng Pao, Cheng-Huei Hsiong, Oliver Yoa-Pu Hu, Jhi-Jung Wang and Shung-Tai Ho
      Drug Metabolism and Disposition March 2005, 33 (3) 395-402; DOI: https://doi.org/10.1124/dmd.104.002451
  8. Hu, Oliver Yoa-Pu

    1. You have access
      IN VITRO AND IN VIVO EVALUATION OF THE METABOLISM AND PHARMACOKINETICS OF SEBACOYL DINALBUPHINE
      Li-Heng Pao, Cheng-Huei Hsiong, Oliver Yoa-Pu Hu, Jhi-Jung Wang and Shung-Tai Ho
      Drug Metabolism and Disposition March 2005, 33 (3) 395-402; DOI: https://doi.org/10.1124/dmd.104.002451
  9. Huang, Shiew-Mei

    1. You have access
      DO MEN AND WOMEN DIFFER IN PROXIMAL SMALL INTESTINAL CYP3A OR P-GLYCOPROTEIN EXPRESSION?
      Mary F. Paine, Shana S. Ludington, Mei-Ling Chen, Paul W. Stewart, Shiew-Mei Huang and Paul B. Watkins
      Drug Metabolism and Disposition March 2005, 33 (3) 426-433; DOI: https://doi.org/10.1124/dmd.104.002469

I

  1. Inada, Makoto

    1. You have access
      RELATIONSHIPS AMONG PLASMA [2-13C]URACIL CONCENTRATIONS, BREATH 13CO2 EXPIRATION, AND DIHYDROPYRIMIDINE DEHYDROGENASE (DPD) ACTIVITY IN THE LIVER IN NORMAL AND DPD-DEFICIENT DOGS
      Makoto Inada, Yukihiro Hirao, Toshihisa Koga, Minoru Itose, Jun-ichi Kunizaki, Takefumi Shimizu and Hitoshi Sato
      Drug Metabolism and Disposition March 2005, 33 (3) 381-387; DOI: https://doi.org/10.1124/dmd.104.001032
  2. Itose, Minoru

    1. You have access
      RELATIONSHIPS AMONG PLASMA [2-13C]URACIL CONCENTRATIONS, BREATH 13CO2 EXPIRATION, AND DIHYDROPYRIMIDINE DEHYDROGENASE (DPD) ACTIVITY IN THE LIVER IN NORMAL AND DPD-DEFICIENT DOGS
      Makoto Inada, Yukihiro Hirao, Toshihisa Koga, Minoru Itose, Jun-ichi Kunizaki, Takefumi Shimizu and Hitoshi Sato
      Drug Metabolism and Disposition March 2005, 33 (3) 381-387; DOI: https://doi.org/10.1124/dmd.104.001032

J

  1. Jinno, Hideto

    1. You have access
      RACIAL VARIABILITY IN HAPLOTYPE FREQUENCIES OF UGT1A1 AND GLUCURONIDATION ACTIVITY OF A NOVEL SINGLE NUCLEOTIDE POLYMORPHISM 686C> T (P229L) FOUND IN AN AFRICAN-AMERICAN
      Nahoko Kaniwa, Kouichi Kurose, Hideto Jinno, Toshiko Tanaka-Kagawa, Yoshiro Saito, Mayumi Saeki, Jun-ichi Sawada, Masahiro Tohkin and Ryuichi Hasegawa
      Drug Metabolism and Disposition March 2005, 33 (3) 458-465; DOI: https://doi.org/10.1124/dmd.104.001800

K

  1. Kaji, Hidefumi

    1. You have access
      REGIOSELECTIVE GLUCURONIDATION OF DENOPAMINE: MARKED SPECIES DIFFERENCES AND IDENTIFICATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASE ISOFORM
      Hidefumi Kaji and Toshiyuki Kume
      Drug Metabolism and Disposition March 2005, 33 (3) 403-412; DOI: https://doi.org/10.1124/dmd.104.002667
  2. Kaminsky, Laurence S.

    1. You have access
      MECHANISMS OF ARSENITE-MEDIATED DECREASES IN BENZO[K]FLUORANTHENE-INDUCED HUMAN CYTOCHROME P4501A1 LEVELS IN HEPG2 CELLS
      Erin E. Bessette, Michael J. Fasco, Brian T. Pentecost and Laurence S. Kaminsky
      Drug Metabolism and Disposition March 2005, 33 (3) 312-320; DOI: https://doi.org/10.1124/dmd.104.002212
  3. Kaniwa, Nahoko

    1. You have access
      RACIAL VARIABILITY IN HAPLOTYPE FREQUENCIES OF UGT1A1 AND GLUCURONIDATION ACTIVITY OF A NOVEL SINGLE NUCLEOTIDE POLYMORPHISM 686C> T (P229L) FOUND IN AN AFRICAN-AMERICAN
      Nahoko Kaniwa, Kouichi Kurose, Hideto Jinno, Toshiko Tanaka-Kagawa, Yoshiro Saito, Mayumi Saeki, Jun-ichi Sawada, Masahiro Tohkin and Ryuichi Hasegawa
      Drug Metabolism and Disposition March 2005, 33 (3) 458-465; DOI: https://doi.org/10.1124/dmd.104.001800
  4. Kato, Yoshihisa

    1. You have access
      COMPARATIVE METABOLISM OF POLYCHLORINATED BIPHENYLS AND TISSUE DISTRIBUTION OF PERSISTENT METABOLITES IN RATS, HAMSTERS, AND GUINEA PIGS
      Koichi Haraguchi, Nobuyuki Koga and Yoshihisa Kato
      Drug Metabolism and Disposition March 2005, 33 (3) 373-380; DOI: https://doi.org/10.1124/dmd.104.002444
  5. Kharasch, Evan D.

    1. You have access
      METABOLISM OF ALFENTANIL BY CYTOCHROME P4503A (CYP3A) ENZYMES
      Theresa Mariero Klees, Pamela Sheffels, Ola Dale and Evan D. Kharasch
      Drug Metabolism and Disposition March 2005, 33 (3) 303-311; DOI: https://doi.org/10.1124/dmd.104.002709
  6. Kim, Dae-Duk

    1. You have access
      SATURABLE DISTRIBUTION OF TACRINE INTO THE STRIATAL EXTRACELLULAR FLUID OF THE RAT: EVIDENCE OF INVOLVEMENT OF MULTIPLE ORGANIC CATION TRANSPORTERS IN THE TRANSPORT
      Jong-Hyuk Sung, Kyung-Ha Yu, Jin-Sun Park, Takashi Tsuruo, Dae-Duk Kim, Chang-Koo Shim and Suk-Jae Chung
      Drug Metabolism and Disposition March 2005, 33 (3) 440-448; DOI: https://doi.org/10.1124/dmd.104.002220
  7. Kirillov, Eugene

    1. You have access
      A NOVEL METHOD FOR VISUALIZING NUCLEAR HORMONE RECEPTOR NETWORKS RELEVANT TO DRUG METABOLISM
      Sean Ekins, Eugene Kirillov, Eugene A. Rakhmatulin and Tatiana Nikolskaya
      Drug Metabolism and Disposition March 2005, 33 (3) 474-481; DOI: https://doi.org/10.1124/dmd.104.002717
  8. Klees, Theresa Mariero

    1. You have access
      METABOLISM OF ALFENTANIL BY CYTOCHROME P4503A (CYP3A) ENZYMES
      Theresa Mariero Klees, Pamela Sheffels, Ola Dale and Evan D. Kharasch
      Drug Metabolism and Disposition March 2005, 33 (3) 303-311; DOI: https://doi.org/10.1124/dmd.104.002709
  9. Koga, Nobuyuki

    1. You have access
      COMPARATIVE METABOLISM OF POLYCHLORINATED BIPHENYLS AND TISSUE DISTRIBUTION OF PERSISTENT METABOLITES IN RATS, HAMSTERS, AND GUINEA PIGS
      Koichi Haraguchi, Nobuyuki Koga and Yoshihisa Kato
      Drug Metabolism and Disposition March 2005, 33 (3) 373-380; DOI: https://doi.org/10.1124/dmd.104.002444
  10. Koga, Toshihisa

    1. You have access
      RELATIONSHIPS AMONG PLASMA [2-13C]URACIL CONCENTRATIONS, BREATH 13CO2 EXPIRATION, AND DIHYDROPYRIMIDINE DEHYDROGENASE (DPD) ACTIVITY IN THE LIVER IN NORMAL AND DPD-DEFICIENT DOGS
      Makoto Inada, Yukihiro Hirao, Toshihisa Koga, Minoru Itose, Jun-ichi Kunizaki, Takefumi Shimizu and Hitoshi Sato
      Drug Metabolism and Disposition March 2005, 33 (3) 381-387; DOI: https://doi.org/10.1124/dmd.104.001032
  11. Krausz, Kristopher W.

    1. You have access
      THE CYP2E1-HUMANIZED TRANSGENIC MOUSE: ROLE OF CYP2E1 IN ACETAMINOPHEN HEPATOTOXICITY
      Connie Cheung, Ai-Ming Yu, Jerrold M. Ward, Kristopher W. Krausz, Taro E. Akiyama, Lionel Feigenbaum and Frank J. Gonzalez
      Drug Metabolism and Disposition March 2005, 33 (3) 449-457; DOI: https://doi.org/10.1124/dmd.104.002402
  12. Kume, Toshiyuki

    1. You have access
      REGIOSELECTIVE GLUCURONIDATION OF DENOPAMINE: MARKED SPECIES DIFFERENCES AND IDENTIFICATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASE ISOFORM
      Hidefumi Kaji and Toshiyuki Kume
      Drug Metabolism and Disposition March 2005, 33 (3) 403-412; DOI: https://doi.org/10.1124/dmd.104.002667
  13. Kunizaki, Jun-ichi

    1. You have access
      RELATIONSHIPS AMONG PLASMA [2-13C]URACIL CONCENTRATIONS, BREATH 13CO2 EXPIRATION, AND DIHYDROPYRIMIDINE DEHYDROGENASE (DPD) ACTIVITY IN THE LIVER IN NORMAL AND DPD-DEFICIENT DOGS
      Makoto Inada, Yukihiro Hirao, Toshihisa Koga, Minoru Itose, Jun-ichi Kunizaki, Takefumi Shimizu and Hitoshi Sato
      Drug Metabolism and Disposition March 2005, 33 (3) 381-387; DOI: https://doi.org/10.1124/dmd.104.001032
  14. Kurose, Kouichi

    1. You have access
      RACIAL VARIABILITY IN HAPLOTYPE FREQUENCIES OF UGT1A1 AND GLUCURONIDATION ACTIVITY OF A NOVEL SINGLE NUCLEOTIDE POLYMORPHISM 686C> T (P229L) FOUND IN AN AFRICAN-AMERICAN
      Nahoko Kaniwa, Kouichi Kurose, Hideto Jinno, Toshiko Tanaka-Kagawa, Yoshiro Saito, Mayumi Saeki, Jun-ichi Sawada, Masahiro Tohkin and Ryuichi Hasegawa
      Drug Metabolism and Disposition March 2005, 33 (3) 458-465; DOI: https://doi.org/10.1124/dmd.104.001800

L

  1. Laufer, Ralph

    1. You have access
      DEVELOPMENT AND VALIDATION OF A HIGH-THROUGHPUT RADIOMETRIC CYP3A4/5 INHIBITION ASSAY USING TRITIATED TESTOSTERONE
      Annalise Di Marco, Isabella Marcucci, Maria Verdirame, José Pérez, Manuel Sanchez, Fernando Peláez, Ashok Chaudhary and Ralph Laufer
      Drug Metabolism and Disposition March 2005, 33 (3) 349-358; DOI: https://doi.org/10.1124/dmd.104.002873
    2. You have access
      DEVELOPMENT AND VALIDATION OF A HIGH-THROUGHPUT RADIOMETRIC CYP2C9 INHIBITION ASSAY USING TRITIATED DICLOFENAC
      Annalise Di Marco, Isabella Marcucci, Ashok Chaudhary, Marina Taliani and Ralph Laufer
      Drug Metabolism and Disposition March 2005, 33 (3) 359-364; DOI: https://doi.org/10.1124/dmd.104.002915
  2. Ludington, Shana S.

    1. You have access
      DO MEN AND WOMEN DIFFER IN PROXIMAL SMALL INTESTINAL CYP3A OR P-GLYCOPROTEIN EXPRESSION?
      Mary F. Paine, Shana S. Ludington, Mei-Ling Chen, Paul W. Stewart, Shiew-Mei Huang and Paul B. Watkins
      Drug Metabolism and Disposition March 2005, 33 (3) 426-433; DOI: https://doi.org/10.1124/dmd.104.002469

M

  1. Marco, Annalise Di

    1. You have access
      DEVELOPMENT AND VALIDATION OF A HIGH-THROUGHPUT RADIOMETRIC CYP3A4/5 INHIBITION ASSAY USING TRITIATED TESTOSTERONE
      Annalise Di Marco, Isabella Marcucci, Maria Verdirame, José Pérez, Manuel Sanchez, Fernando Peláez, Ashok Chaudhary and Ralph Laufer
      Drug Metabolism and Disposition March 2005, 33 (3) 349-358; DOI: https://doi.org/10.1124/dmd.104.002873
  2. Marcucci, Isabella

    1. You have access
      DEVELOPMENT AND VALIDATION OF A HIGH-THROUGHPUT RADIOMETRIC CYP3A4/5 INHIBITION ASSAY USING TRITIATED TESTOSTERONE
      Annalise Di Marco, Isabella Marcucci, Maria Verdirame, José Pérez, Manuel Sanchez, Fernando Peláez, Ashok Chaudhary and Ralph Laufer
      Drug Metabolism and Disposition March 2005, 33 (3) 349-358; DOI: https://doi.org/10.1124/dmd.104.002873
    2. You have access
      DEVELOPMENT AND VALIDATION OF A HIGH-THROUGHPUT RADIOMETRIC CYP2C9 INHIBITION ASSAY USING TRITIATED DICLOFENAC
      Annalise Di Marco, Isabella Marcucci, Ashok Chaudhary, Marina Taliani and Ralph Laufer
      Drug Metabolism and Disposition March 2005, 33 (3) 359-364; DOI: https://doi.org/10.1124/dmd.104.002915
  3. Meneguz, Annarita

    1. You have access
      MALATHION BIOACTIVATION IN THE HUMAN LIVER: THE CONTRIBUTION OF DIFFERENT CYTOCHROME P450 ISOFORMS
      Franca M. Buratti, Alessandra D'Aniello, Maria Teresa Volpe, Annarita Meneguz and Emanuela Testai
      Drug Metabolism and Disposition March 2005, 33 (3) 295-302; DOI: https://doi.org/10.1124/dmd.104.001693
  4. Minami, Hironobu

    1. You have access
      ROLE OF ORGANIC ANION TRANSPORTER OATP1B1 (OATP-C) IN HEPATIC UPTAKE OF IRINOTECAN AND ITS ACTIVE METABOLITE, 7-ETHYL-10-HYDROXYCAMPTOTHECIN: IN VITRO EVIDENCE AND EFFECT OF SINGLE NUCLEOTIDE POLYMORPHISMS
      Takashi Nozawa, Hironobu Minami, Shigeki Sugiura, Akira Tsuji and Ikumi Tamai
      Drug Metabolism and Disposition March 2005, 33 (3) 434-439; DOI: https://doi.org/10.1124/dmd.104.001909
  5. Mohmed, Sarfraz

    1. You have access
      THE BINDING OF DRUGS TO HEPATOCYTES AND ITS RELATIONSHIP TO PHYSICOCHEMICAL PROPERTIES
      Rupert P. Austin, Patrick Barton, Sarfraz Mohmed and Robert J. Riley
      Drug Metabolism and Disposition March 2005, 33 (3) 419-425; DOI: https://doi.org/10.1124/dmd.104.002436
  6. Morris, Marilyn E.

    1. You have access
      NEW 4-ARYL-1,4-DIHYDROPYRIDINES AND 4-ARYLPYRIDINES AS P-GLYCOPROTEIN INHIBITORS
      Xiao-fei Zhou, Linping Zhang, Elaine Tseng, Elizabeth Scott-Ramsay, Jerome J. Schentag, Robert A. Coburn and Marilyn E. Morris
      Drug Metabolism and Disposition March 2005, 33 (3) 321-328; DOI: https://doi.org/10.1124/dmd.104.002089
    2. You have access
      FLAVONOIDS CHRYSIN AND BENZOFLAVONE, POTENT BREAST CANCER RESISTANCE PROTEIN INHIBITORS, HAVE NO SIGNIFICANT EFFECT ON TOPOTECAN PHARMACOKINETICS IN RATS OR MDR1A/1B (–/–) MICE
      Shuzhong Zhang, Xiaodong Wang, Kazuko Sagawa and Marilyn E. Morris
      Drug Metabolism and Disposition March 2005, 33 (3) 341-348; DOI: https://doi.org/10.1124/dmd.104.002501

N

  1. Nikolskaya, Tatiana

    1. You have access
      A NOVEL METHOD FOR VISUALIZING NUCLEAR HORMONE RECEPTOR NETWORKS RELEVANT TO DRUG METABOLISM
      Sean Ekins, Eugene Kirillov, Eugene A. Rakhmatulin and Tatiana Nikolskaya
      Drug Metabolism and Disposition March 2005, 33 (3) 474-481; DOI: https://doi.org/10.1124/dmd.104.002717
  2. Nozawa, Takashi

    1. You have access
      ROLE OF ORGANIC ANION TRANSPORTER OATP1B1 (OATP-C) IN HEPATIC UPTAKE OF IRINOTECAN AND ITS ACTIVE METABOLITE, 7-ETHYL-10-HYDROXYCAMPTOTHECIN: IN VITRO EVIDENCE AND EFFECT OF SINGLE NUCLEOTIDE POLYMORPHISMS
      Takashi Nozawa, Hironobu Minami, Shigeki Sugiura, Akira Tsuji and Ikumi Tamai
      Drug Metabolism and Disposition March 2005, 33 (3) 434-439; DOI: https://doi.org/10.1124/dmd.104.001909

O

  1. Obach, R. Scott

    1. You have access
      SELECTIVE INHIBITION OF HUMAN CYTOCHROME P4502C8 BY MONTELUKAST
      Robert L. Walsky, R. Scott Obach, Emily A. Gaman, Jean-Paul R. Gleeson and William R. Proctor
      Drug Metabolism and Disposition March 2005, 33 (3) 413-418; DOI: https://doi.org/10.1124/dmd.104.002766
  2. Ou, Junhai

    1. You have access
      PHARMACOKINETICS OF TACROLIMUS AND MYCOPHENOLIC ACID ARE ALTERED, BUT RECOVER AT DIFFERENT TIMES DURING HEPATIC REGENERATION IN RATS
      Hui Tian, Junhai Ou, Stephen C. Strom and Raman Venkataramanan
      Drug Metabolism and Disposition March 2005, 33 (3) 329-335; DOI: https://doi.org/10.1124/dmd.104.002287

P

  1. Paine, Mary F.

    1. You have access
      DO MEN AND WOMEN DIFFER IN PROXIMAL SMALL INTESTINAL CYP3A OR P-GLYCOPROTEIN EXPRESSION?
      Mary F. Paine, Shana S. Ludington, Mei-Ling Chen, Paul W. Stewart, Shiew-Mei Huang and Paul B. Watkins
      Drug Metabolism and Disposition March 2005, 33 (3) 426-433; DOI: https://doi.org/10.1124/dmd.104.002469
  2. Pao, Li-Heng

    1. You have access
      IN VITRO AND IN VIVO EVALUATION OF THE METABOLISM AND PHARMACOKINETICS OF SEBACOYL DINALBUPHINE
      Li-Heng Pao, Cheng-Huei Hsiong, Oliver Yoa-Pu Hu, Jhi-Jung Wang and Shung-Tai Ho
      Drug Metabolism and Disposition March 2005, 33 (3) 395-402; DOI: https://doi.org/10.1124/dmd.104.002451
  3. Park, Jin-Sun

    1. You have access
      SATURABLE DISTRIBUTION OF TACRINE INTO THE STRIATAL EXTRACELLULAR FLUID OF THE RAT: EVIDENCE OF INVOLVEMENT OF MULTIPLE ORGANIC CATION TRANSPORTERS IN THE TRANSPORT
      Jong-Hyuk Sung, Kyung-Ha Yu, Jin-Sun Park, Takashi Tsuruo, Dae-Duk Kim, Chang-Koo Shim and Suk-Jae Chung
      Drug Metabolism and Disposition March 2005, 33 (3) 440-448; DOI: https://doi.org/10.1124/dmd.104.002220
  4. Peláez, Fernando

    1. You have access
      DEVELOPMENT AND VALIDATION OF A HIGH-THROUGHPUT RADIOMETRIC CYP3A4/5 INHIBITION ASSAY USING TRITIATED TESTOSTERONE
      Annalise Di Marco, Isabella Marcucci, Maria Verdirame, José Pérez, Manuel Sanchez, Fernando Peláez, Ashok Chaudhary and Ralph Laufer
      Drug Metabolism and Disposition March 2005, 33 (3) 349-358; DOI: https://doi.org/10.1124/dmd.104.002873
  5. Pentecost, Brian T.

    1. You have access
      MECHANISMS OF ARSENITE-MEDIATED DECREASES IN BENZO[K]FLUORANTHENE-INDUCED HUMAN CYTOCHROME P4501A1 LEVELS IN HEPG2 CELLS
      Erin E. Bessette, Michael J. Fasco, Brian T. Pentecost and Laurence S. Kaminsky
      Drug Metabolism and Disposition March 2005, 33 (3) 312-320; DOI: https://doi.org/10.1124/dmd.104.002212
  6. Pérez, José

    1. You have access
      DEVELOPMENT AND VALIDATION OF A HIGH-THROUGHPUT RADIOMETRIC CYP3A4/5 INHIBITION ASSAY USING TRITIATED TESTOSTERONE
      Annalise Di Marco, Isabella Marcucci, Maria Verdirame, José Pérez, Manuel Sanchez, Fernando Peláez, Ashok Chaudhary and Ralph Laufer
      Drug Metabolism and Disposition March 2005, 33 (3) 349-358; DOI: https://doi.org/10.1124/dmd.104.002873
  7. Perrin, L.

    1. You have access
      CYTOCHROME P450-MEDIATED OXIDATION OF GLUCURONIDE DERIVATIVES: EXAMPLE OF ESTRADIOL-17β-GLUCURONIDE OXIDATION TO 2-HYDROXY-ESTRADIOL-17β-GLUCURONIDE BY CYP 2C8
      M. Delaforge, A. Pruvost, L. Perrin and F. André
      Drug Metabolism and Disposition March 2005, 33 (3) 466-473; DOI: https://doi.org/10.1124/dmd.104.002097
  8. Proctor, William R.

    1. You have access
      SELECTIVE INHIBITION OF HUMAN CYTOCHROME P4502C8 BY MONTELUKAST
      Robert L. Walsky, R. Scott Obach, Emily A. Gaman, Jean-Paul R. Gleeson and William R. Proctor
      Drug Metabolism and Disposition March 2005, 33 (3) 413-418; DOI: https://doi.org/10.1124/dmd.104.002766
  9. Pruvost, A.

    1. You have access
      CYTOCHROME P450-MEDIATED OXIDATION OF GLUCURONIDE DERIVATIVES: EXAMPLE OF ESTRADIOL-17β-GLUCURONIDE OXIDATION TO 2-HYDROXY-ESTRADIOL-17β-GLUCURONIDE BY CYP 2C8
      M. Delaforge, A. Pruvost, L. Perrin and F. André
      Drug Metabolism and Disposition March 2005, 33 (3) 466-473; DOI: https://doi.org/10.1124/dmd.104.002097

R

  1. Rakhmatulin, Eugene A.

    1. You have access
      A NOVEL METHOD FOR VISUALIZING NUCLEAR HORMONE RECEPTOR NETWORKS RELEVANT TO DRUG METABOLISM
      Sean Ekins, Eugene Kirillov, Eugene A. Rakhmatulin and Tatiana Nikolskaya
      Drug Metabolism and Disposition March 2005, 33 (3) 474-481; DOI: https://doi.org/10.1124/dmd.104.002717
  2. Riley, Robert J.

    1. You have access
      THE BINDING OF DRUGS TO HEPATOCYTES AND ITS RELATIONSHIP TO PHYSICOCHEMICAL PROPERTIES
      Rupert P. Austin, Patrick Barton, Sarfraz Mohmed and Robert J. Riley
      Drug Metabolism and Disposition March 2005, 33 (3) 419-425; DOI: https://doi.org/10.1124/dmd.104.002436

S

  1. Saeki, Mayumi

    1. You have access
      RACIAL VARIABILITY IN HAPLOTYPE FREQUENCIES OF UGT1A1 AND GLUCURONIDATION ACTIVITY OF A NOVEL SINGLE NUCLEOTIDE POLYMORPHISM 686C> T (P229L) FOUND IN AN AFRICAN-AMERICAN
      Nahoko Kaniwa, Kouichi Kurose, Hideto Jinno, Toshiko Tanaka-Kagawa, Yoshiro Saito, Mayumi Saeki, Jun-ichi Sawada, Masahiro Tohkin and Ryuichi Hasegawa
      Drug Metabolism and Disposition March 2005, 33 (3) 458-465; DOI: https://doi.org/10.1124/dmd.104.001800
  2. Sagawa, Kazuko

    1. You have access
      FLAVONOIDS CHRYSIN AND BENZOFLAVONE, POTENT BREAST CANCER RESISTANCE PROTEIN INHIBITORS, HAVE NO SIGNIFICANT EFFECT ON TOPOTECAN PHARMACOKINETICS IN RATS OR MDR1A/1B (–/–) MICE
      Shuzhong Zhang, Xiaodong Wang, Kazuko Sagawa and Marilyn E. Morris
      Drug Metabolism and Disposition March 2005, 33 (3) 341-348; DOI: https://doi.org/10.1124/dmd.104.002501
  3. Saito, Yoshiro

    1. You have access
      RACIAL VARIABILITY IN HAPLOTYPE FREQUENCIES OF UGT1A1 AND GLUCURONIDATION ACTIVITY OF A NOVEL SINGLE NUCLEOTIDE POLYMORPHISM 686C> T (P229L) FOUND IN AN AFRICAN-AMERICAN
      Nahoko Kaniwa, Kouichi Kurose, Hideto Jinno, Toshiko Tanaka-Kagawa, Yoshiro Saito, Mayumi Saeki, Jun-ichi Sawada, Masahiro Tohkin and Ryuichi Hasegawa
      Drug Metabolism and Disposition March 2005, 33 (3) 458-465; DOI: https://doi.org/10.1124/dmd.104.001800
  4. Sanchez, Manuel

    1. You have access
      DEVELOPMENT AND VALIDATION OF A HIGH-THROUGHPUT RADIOMETRIC CYP3A4/5 INHIBITION ASSAY USING TRITIATED TESTOSTERONE
      Annalise Di Marco, Isabella Marcucci, Maria Verdirame, José Pérez, Manuel Sanchez, Fernando Peláez, Ashok Chaudhary and Ralph Laufer
      Drug Metabolism and Disposition March 2005, 33 (3) 349-358; DOI: https://doi.org/10.1124/dmd.104.002873
  5. Sato, Hitoshi

    1. You have access
      RELATIONSHIPS AMONG PLASMA [2-13C]URACIL CONCENTRATIONS, BREATH 13CO2 EXPIRATION, AND DIHYDROPYRIMIDINE DEHYDROGENASE (DPD) ACTIVITY IN THE LIVER IN NORMAL AND DPD-DEFICIENT DOGS
      Makoto Inada, Yukihiro Hirao, Toshihisa Koga, Minoru Itose, Jun-ichi Kunizaki, Takefumi Shimizu and Hitoshi Sato
      Drug Metabolism and Disposition March 2005, 33 (3) 381-387; DOI: https://doi.org/10.1124/dmd.104.001032
  6. Sawada, Jun-ichi

    1. You have access
      RACIAL VARIABILITY IN HAPLOTYPE FREQUENCIES OF UGT1A1 AND GLUCURONIDATION ACTIVITY OF A NOVEL SINGLE NUCLEOTIDE POLYMORPHISM 686C> T (P229L) FOUND IN AN AFRICAN-AMERICAN
      Nahoko Kaniwa, Kouichi Kurose, Hideto Jinno, Toshiko Tanaka-Kagawa, Yoshiro Saito, Mayumi Saeki, Jun-ichi Sawada, Masahiro Tohkin and Ryuichi Hasegawa
      Drug Metabolism and Disposition March 2005, 33 (3) 458-465; DOI: https://doi.org/10.1124/dmd.104.001800
  7. Schentag, Jerome J.

    1. You have access
      NEW 4-ARYL-1,4-DIHYDROPYRIDINES AND 4-ARYLPYRIDINES AS P-GLYCOPROTEIN INHIBITORS
      Xiao-fei Zhou, Linping Zhang, Elaine Tseng, Elizabeth Scott-Ramsay, Jerome J. Schentag, Robert A. Coburn and Marilyn E. Morris
      Drug Metabolism and Disposition March 2005, 33 (3) 321-328; DOI: https://doi.org/10.1124/dmd.104.002089
  8. Scott-Ramsay, Elizabeth

    1. You have access
      NEW 4-ARYL-1,4-DIHYDROPYRIDINES AND 4-ARYLPYRIDINES AS P-GLYCOPROTEIN INHIBITORS
      Xiao-fei Zhou, Linping Zhang, Elaine Tseng, Elizabeth Scott-Ramsay, Jerome J. Schentag, Robert A. Coburn and Marilyn E. Morris
      Drug Metabolism and Disposition March 2005, 33 (3) 321-328; DOI: https://doi.org/10.1124/dmd.104.002089
  9. Sheffels, Pamela

    1. You have access
      METABOLISM OF ALFENTANIL BY CYTOCHROME P4503A (CYP3A) ENZYMES
      Theresa Mariero Klees, Pamela Sheffels, Ola Dale and Evan D. Kharasch
      Drug Metabolism and Disposition March 2005, 33 (3) 303-311; DOI: https://doi.org/10.1124/dmd.104.002709
  10. Shim, Chang-Koo

    1. You have access
      SATURABLE DISTRIBUTION OF TACRINE INTO THE STRIATAL EXTRACELLULAR FLUID OF THE RAT: EVIDENCE OF INVOLVEMENT OF MULTIPLE ORGANIC CATION TRANSPORTERS IN THE TRANSPORT
      Jong-Hyuk Sung, Kyung-Ha Yu, Jin-Sun Park, Takashi Tsuruo, Dae-Duk Kim, Chang-Koo Shim and Suk-Jae Chung
      Drug Metabolism and Disposition March 2005, 33 (3) 440-448; DOI: https://doi.org/10.1124/dmd.104.002220
  11. Shimizu, Takefumi

    1. You have access
      RELATIONSHIPS AMONG PLASMA [2-13C]URACIL CONCENTRATIONS, BREATH 13CO2 EXPIRATION, AND DIHYDROPYRIMIDINE DEHYDROGENASE (DPD) ACTIVITY IN THE LIVER IN NORMAL AND DPD-DEFICIENT DOGS
      Makoto Inada, Yukihiro Hirao, Toshihisa Koga, Minoru Itose, Jun-ichi Kunizaki, Takefumi Shimizu and Hitoshi Sato
      Drug Metabolism and Disposition March 2005, 33 (3) 381-387; DOI: https://doi.org/10.1124/dmd.104.001032
  12. Stewart, Paul W.

    1. You have access
      DO MEN AND WOMEN DIFFER IN PROXIMAL SMALL INTESTINAL CYP3A OR P-GLYCOPROTEIN EXPRESSION?
      Mary F. Paine, Shana S. Ludington, Mei-Ling Chen, Paul W. Stewart, Shiew-Mei Huang and Paul B. Watkins
      Drug Metabolism and Disposition March 2005, 33 (3) 426-433; DOI: https://doi.org/10.1124/dmd.104.002469
  13. Strom, Stephen C.

    1. You have access
      PHARMACOKINETICS OF TACROLIMUS AND MYCOPHENOLIC ACID ARE ALTERED, BUT RECOVER AT DIFFERENT TIMES DURING HEPATIC REGENERATION IN RATS
      Hui Tian, Junhai Ou, Stephen C. Strom and Raman Venkataramanan
      Drug Metabolism and Disposition March 2005, 33 (3) 329-335; DOI: https://doi.org/10.1124/dmd.104.002287
  14. Sugiura, Shigeki

    1. You have access
      ROLE OF ORGANIC ANION TRANSPORTER OATP1B1 (OATP-C) IN HEPATIC UPTAKE OF IRINOTECAN AND ITS ACTIVE METABOLITE, 7-ETHYL-10-HYDROXYCAMPTOTHECIN: IN VITRO EVIDENCE AND EFFECT OF SINGLE NUCLEOTIDE POLYMORPHISMS
      Takashi Nozawa, Hironobu Minami, Shigeki Sugiura, Akira Tsuji and Ikumi Tamai
      Drug Metabolism and Disposition March 2005, 33 (3) 434-439; DOI: https://doi.org/10.1124/dmd.104.001909
  15. Sung, Jong-Hyuk

    1. You have access
      SATURABLE DISTRIBUTION OF TACRINE INTO THE STRIATAL EXTRACELLULAR FLUID OF THE RAT: EVIDENCE OF INVOLVEMENT OF MULTIPLE ORGANIC CATION TRANSPORTERS IN THE TRANSPORT
      Jong-Hyuk Sung, Kyung-Ha Yu, Jin-Sun Park, Takashi Tsuruo, Dae-Duk Kim, Chang-Koo Shim and Suk-Jae Chung
      Drug Metabolism and Disposition March 2005, 33 (3) 440-448; DOI: https://doi.org/10.1124/dmd.104.002220

T

  1. Taliani, Marina

    1. You have access
      DEVELOPMENT AND VALIDATION OF A HIGH-THROUGHPUT RADIOMETRIC CYP2C9 INHIBITION ASSAY USING TRITIATED DICLOFENAC
      Annalise Di Marco, Isabella Marcucci, Ashok Chaudhary, Marina Taliani and Ralph Laufer
      Drug Metabolism and Disposition March 2005, 33 (3) 359-364; DOI: https://doi.org/10.1124/dmd.104.002915
  2. Tamai, Ikumi

    1. You have access
      ROLE OF ORGANIC ANION TRANSPORTER OATP1B1 (OATP-C) IN HEPATIC UPTAKE OF IRINOTECAN AND ITS ACTIVE METABOLITE, 7-ETHYL-10-HYDROXYCAMPTOTHECIN: IN VITRO EVIDENCE AND EFFECT OF SINGLE NUCLEOTIDE POLYMORPHISMS
      Takashi Nozawa, Hironobu Minami, Shigeki Sugiura, Akira Tsuji and Ikumi Tamai
      Drug Metabolism and Disposition March 2005, 33 (3) 434-439; DOI: https://doi.org/10.1124/dmd.104.001909
  3. Tanaka-Kagawa, Toshiko

    1. You have access
      RACIAL VARIABILITY IN HAPLOTYPE FREQUENCIES OF UGT1A1 AND GLUCURONIDATION ACTIVITY OF A NOVEL SINGLE NUCLEOTIDE POLYMORPHISM 686C> T (P229L) FOUND IN AN AFRICAN-AMERICAN
      Nahoko Kaniwa, Kouichi Kurose, Hideto Jinno, Toshiko Tanaka-Kagawa, Yoshiro Saito, Mayumi Saeki, Jun-ichi Sawada, Masahiro Tohkin and Ryuichi Hasegawa
      Drug Metabolism and Disposition March 2005, 33 (3) 458-465; DOI: https://doi.org/10.1124/dmd.104.001800
  4. Testai, Emanuela

    1. You have access
      MALATHION BIOACTIVATION IN THE HUMAN LIVER: THE CONTRIBUTION OF DIFFERENT CYTOCHROME P450 ISOFORMS
      Franca M. Buratti, Alessandra D'Aniello, Maria Teresa Volpe, Annarita Meneguz and Emanuela Testai
      Drug Metabolism and Disposition March 2005, 33 (3) 295-302; DOI: https://doi.org/10.1124/dmd.104.001693
  5. Tian, Hui

    1. You have access
      PHARMACOKINETICS OF TACROLIMUS AND MYCOPHENOLIC ACID ARE ALTERED, BUT RECOVER AT DIFFERENT TIMES DURING HEPATIC REGENERATION IN RATS
      Hui Tian, Junhai Ou, Stephen C. Strom and Raman Venkataramanan
      Drug Metabolism and Disposition March 2005, 33 (3) 329-335; DOI: https://doi.org/10.1124/dmd.104.002287
  6. Tohkin, Masahiro

    1. You have access
      RACIAL VARIABILITY IN HAPLOTYPE FREQUENCIES OF UGT1A1 AND GLUCURONIDATION ACTIVITY OF A NOVEL SINGLE NUCLEOTIDE POLYMORPHISM 686C> T (P229L) FOUND IN AN AFRICAN-AMERICAN
      Nahoko Kaniwa, Kouichi Kurose, Hideto Jinno, Toshiko Tanaka-Kagawa, Yoshiro Saito, Mayumi Saeki, Jun-ichi Sawada, Masahiro Tohkin and Ryuichi Hasegawa
      Drug Metabolism and Disposition March 2005, 33 (3) 458-465; DOI: https://doi.org/10.1124/dmd.104.001800
  7. Tseng, Elaine

    1. You have access
      NEW 4-ARYL-1,4-DIHYDROPYRIDINES AND 4-ARYLPYRIDINES AS P-GLYCOPROTEIN INHIBITORS
      Xiao-fei Zhou, Linping Zhang, Elaine Tseng, Elizabeth Scott-Ramsay, Jerome J. Schentag, Robert A. Coburn and Marilyn E. Morris
      Drug Metabolism and Disposition March 2005, 33 (3) 321-328; DOI: https://doi.org/10.1124/dmd.104.002089
  8. Tsuji, Akira

    1. You have access
      ROLE OF ORGANIC ANION TRANSPORTER OATP1B1 (OATP-C) IN HEPATIC UPTAKE OF IRINOTECAN AND ITS ACTIVE METABOLITE, 7-ETHYL-10-HYDROXYCAMPTOTHECIN: IN VITRO EVIDENCE AND EFFECT OF SINGLE NUCLEOTIDE POLYMORPHISMS
      Takashi Nozawa, Hironobu Minami, Shigeki Sugiura, Akira Tsuji and Ikumi Tamai
      Drug Metabolism and Disposition March 2005, 33 (3) 434-439; DOI: https://doi.org/10.1124/dmd.104.001909
  9. Tsuruo, Takashi

    1. You have access
      SATURABLE DISTRIBUTION OF TACRINE INTO THE STRIATAL EXTRACELLULAR FLUID OF THE RAT: EVIDENCE OF INVOLVEMENT OF MULTIPLE ORGANIC CATION TRANSPORTERS IN THE TRANSPORT
      Jong-Hyuk Sung, Kyung-Ha Yu, Jin-Sun Park, Takashi Tsuruo, Dae-Duk Kim, Chang-Koo Shim and Suk-Jae Chung
      Drug Metabolism and Disposition March 2005, 33 (3) 440-448; DOI: https://doi.org/10.1124/dmd.104.002220

V

  1. Venkataramanan, Raman

    1. You have access
      PHARMACOKINETICS OF TACROLIMUS AND MYCOPHENOLIC ACID ARE ALTERED, BUT RECOVER AT DIFFERENT TIMES DURING HEPATIC REGENERATION IN RATS
      Hui Tian, Junhai Ou, Stephen C. Strom and Raman Venkataramanan
      Drug Metabolism and Disposition March 2005, 33 (3) 329-335; DOI: https://doi.org/10.1124/dmd.104.002287
  2. Verdirame, Maria

    1. You have access
      DEVELOPMENT AND VALIDATION OF A HIGH-THROUGHPUT RADIOMETRIC CYP3A4/5 INHIBITION ASSAY USING TRITIATED TESTOSTERONE
      Annalise Di Marco, Isabella Marcucci, Maria Verdirame, José Pérez, Manuel Sanchez, Fernando Peláez, Ashok Chaudhary and Ralph Laufer
      Drug Metabolism and Disposition March 2005, 33 (3) 349-358; DOI: https://doi.org/10.1124/dmd.104.002873
  3. Volpe, Maria Teresa

    1. You have access
      MALATHION BIOACTIVATION IN THE HUMAN LIVER: THE CONTRIBUTION OF DIFFERENT CYTOCHROME P450 ISOFORMS
      Franca M. Buratti, Alessandra D'Aniello, Maria Teresa Volpe, Annarita Meneguz and Emanuela Testai
      Drug Metabolism and Disposition March 2005, 33 (3) 295-302; DOI: https://doi.org/10.1124/dmd.104.001693

W

  1. Walsky, Robert L.

    1. You have access
      SELECTIVE INHIBITION OF HUMAN CYTOCHROME P4502C8 BY MONTELUKAST
      Robert L. Walsky, R. Scott Obach, Emily A. Gaman, Jean-Paul R. Gleeson and William R. Proctor
      Drug Metabolism and Disposition March 2005, 33 (3) 413-418; DOI: https://doi.org/10.1124/dmd.104.002766
  2. Wang, Jhi-Jung

    1. You have access
      IN VITRO AND IN VIVO EVALUATION OF THE METABOLISM AND PHARMACOKINETICS OF SEBACOYL DINALBUPHINE
      Li-Heng Pao, Cheng-Huei Hsiong, Oliver Yoa-Pu Hu, Jhi-Jung Wang and Shung-Tai Ho
      Drug Metabolism and Disposition March 2005, 33 (3) 395-402; DOI: https://doi.org/10.1124/dmd.104.002451
  3. Wang, Shou-Lin

    1. You have access
      HUMAN CYTOCHROME P450 2S1: LACK OF ACTIVITY IN THE METABOLIC ACTIVATION OF SEVERAL CIGARETTE SMOKE CARCINOGENS AND IN THE METABOLISM OF NICOTINE
      Shou-Lin Wang, Xiao-Yang He and Jun-Yan Hong
      Drug Metabolism and Disposition March 2005, 33 (3) 336-340; DOI: https://doi.org/10.1124/dmd.104.002923
  4. Wang, Xiaodong

    1. You have access
      FLAVONOIDS CHRYSIN AND BENZOFLAVONE, POTENT BREAST CANCER RESISTANCE PROTEIN INHIBITORS, HAVE NO SIGNIFICANT EFFECT ON TOPOTECAN PHARMACOKINETICS IN RATS OR MDR1A/1B (–/–) MICE
      Shuzhong Zhang, Xiaodong Wang, Kazuko Sagawa and Marilyn E. Morris
      Drug Metabolism and Disposition March 2005, 33 (3) 341-348; DOI: https://doi.org/10.1124/dmd.104.002501
  5. Ward, Jerrold M.

    1. You have access
      THE CYP2E1-HUMANIZED TRANSGENIC MOUSE: ROLE OF CYP2E1 IN ACETAMINOPHEN HEPATOTOXICITY
      Connie Cheung, Ai-Ming Yu, Jerrold M. Ward, Kristopher W. Krausz, Taro E. Akiyama, Lionel Feigenbaum and Frank J. Gonzalez
      Drug Metabolism and Disposition March 2005, 33 (3) 449-457; DOI: https://doi.org/10.1124/dmd.104.002402
  6. Watkins, Paul B.

    1. You have access
      DO MEN AND WOMEN DIFFER IN PROXIMAL SMALL INTESTINAL CYP3A OR P-GLYCOPROTEIN EXPRESSION?
      Mary F. Paine, Shana S. Ludington, Mei-Ling Chen, Paul W. Stewart, Shiew-Mei Huang and Paul B. Watkins
      Drug Metabolism and Disposition March 2005, 33 (3) 426-433; DOI: https://doi.org/10.1124/dmd.104.002469

Y

  1. Yu, Ai-Ming

    1. You have access
      THE CYP2E1-HUMANIZED TRANSGENIC MOUSE: ROLE OF CYP2E1 IN ACETAMINOPHEN HEPATOTOXICITY
      Connie Cheung, Ai-Ming Yu, Jerrold M. Ward, Kristopher W. Krausz, Taro E. Akiyama, Lionel Feigenbaum and Frank J. Gonzalez
      Drug Metabolism and Disposition March 2005, 33 (3) 449-457; DOI: https://doi.org/10.1124/dmd.104.002402
  2. Yu, Kyung-Ha

    1. You have access
      SATURABLE DISTRIBUTION OF TACRINE INTO THE STRIATAL EXTRACELLULAR FLUID OF THE RAT: EVIDENCE OF INVOLVEMENT OF MULTIPLE ORGANIC CATION TRANSPORTERS IN THE TRANSPORT
      Jong-Hyuk Sung, Kyung-Ha Yu, Jin-Sun Park, Takashi Tsuruo, Dae-Duk Kim, Chang-Koo Shim and Suk-Jae Chung
      Drug Metabolism and Disposition March 2005, 33 (3) 440-448; DOI: https://doi.org/10.1124/dmd.104.002220

Z

  1. Zhang, Linping

    1. You have access
      NEW 4-ARYL-1,4-DIHYDROPYRIDINES AND 4-ARYLPYRIDINES AS P-GLYCOPROTEIN INHIBITORS
      Xiao-fei Zhou, Linping Zhang, Elaine Tseng, Elizabeth Scott-Ramsay, Jerome J. Schentag, Robert A. Coburn and Marilyn E. Morris
      Drug Metabolism and Disposition March 2005, 33 (3) 321-328; DOI: https://doi.org/10.1124/dmd.104.002089
  2. Zhang, Shuzhong

    1. You have access
      FLAVONOIDS CHRYSIN AND BENZOFLAVONE, POTENT BREAST CANCER RESISTANCE PROTEIN INHIBITORS, HAVE NO SIGNIFICANT EFFECT ON TOPOTECAN PHARMACOKINETICS IN RATS OR MDR1A/1B (–/–) MICE
      Shuzhong Zhang, Xiaodong Wang, Kazuko Sagawa and Marilyn E. Morris
      Drug Metabolism and Disposition March 2005, 33 (3) 341-348; DOI: https://doi.org/10.1124/dmd.104.002501
  3. Zhou, Xiao-fei

    1. You have access
      NEW 4-ARYL-1,4-DIHYDROPYRIDINES AND 4-ARYLPYRIDINES AS P-GLYCOPROTEIN INHIBITORS
      Xiao-fei Zhou, Linping Zhang, Elaine Tseng, Elizabeth Scott-Ramsay, Jerome J. Schentag, Robert A. Coburn and Marilyn E. Morris
      Drug Metabolism and Disposition March 2005, 33 (3) 321-328; DOI: https://doi.org/10.1124/dmd.104.002089
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 33 (3)
Drug Metabolism and Disposition
Vol. 33, Issue 3
1 Mar 2005
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts
  • Most Read
Loading
  • PBPK Modeling for Clopidogrel and Its Active Metabolite
  • Physiology of the Neonatal Gastrointestinal System
  • Pharmacokinetics and Disposition of Biologics
  • Tissue Drug Concentrations: Beyond the Free Drug Hypothesis
  • Metabolism and Disposition of Volanesorsen across Species
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics